SlideShare a Scribd company logo
1 of 91
INTRODUCTION   TO  HEMATOLOGY Erlinda E. Samson-Cruz, MD, FPCP, FPSHBT
HEMATOLOGY ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Elements of blood ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Cellular elements ,[object Object],[object Object],[object Object]
Cellular elements ,[object Object],[object Object]
Cellular elements ,[object Object]
Cellular elements ,[object Object],[object Object],[object Object],[object Object]
Cellular elements ,[object Object],[object Object],[object Object],[object Object],[object Object]
Cellular elements ,[object Object],[object Object],[object Object]
Cellular elements ,[object Object],[object Object],[object Object],[object Object],[object Object]
Cellular elements ,[object Object],[object Object],[object Object],[object Object]
Cellular elements ,[object Object],[object Object],[object Object],[object Object],[object Object]
Cellular elements ,[object Object],[object Object],[object Object],[object Object],[object Object]
Cellular elements ,[object Object],[object Object],[object Object],[object Object],[object Object]
Cellular elements ,[object Object],[object Object],[object Object],[object Object],[object Object]
PRINCIPLES OF HEMATOLOGIC DIAGNOSIS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
PRINCIPLES OF HEMATOLOGIC DIAGNOSIS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
LABORATORY EVALUATION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
LABORATORY EVALUATION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
LABORATORY EVALUATION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
LABORATORY EVALUATION ,[object Object],[object Object],[object Object],[object Object],[object Object]
LABORATORY EVALUATION ,[object Object],[object Object],[object Object]
LABORATORY EVALUATION ,[object Object],[object Object],[object Object],[object Object]
LABORATORY EVALUATION ,[object Object],[object Object],[object Object],[object Object],[object Object]
LABORATORY EVALUATION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
RETICULOCYTE COUNT  1 st  CORRECTION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
RETICULOCYTE COUNT  2 nd  CORRECTION ,[object Object],[object Object],[object Object]
RETICULOCYTE COUNT  2 nd  CORRECTION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
LABORATORY EVALUATION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Bone marrow aspiration
Bone marrow aspiration
Sites of BMA
LABORATORY EVALUATION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
How to examine a bone marrow aspirate
Bone marrow aspirate ,[object Object],[object Object],[object Object]
Bone marrow aspirate ,[object Object],[object Object]
Bone marrow aspirate ,[object Object],[object Object],[object Object],[object Object]
Bone marrow aspirate ,[object Object],[object Object]
SITES OF HEMATOPOIESIS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
SITES OF HEMATOPOIESIS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
SITES OF HEMATOPOIESIS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Hematopoiesis  ,[object Object],[object Object]
Hematopoiesis  ,[object Object],[object Object]
HEMATOPOIESIS PLURIPOTENT  STEM CELL MYELOID  MULTIPOTENT STEM CELL LYMPHOID  MULTIPOTENT STEM CELL LYMPHOCYTES BFU-EYTHROID MEG  PROGENITOR CFU-MEG GRAN/MONO PROGENITOR CFU-GM EO  PROGENITOR CFU-Eo E PROGENITOR CFU-E RBC PLATELET MONOCYTE NEUTROPHIL BASOPHIL EOSINOPHIL
ERYTHROPOIESIS
ERYTHROPOIESIS ,[object Object],[object Object],[object Object],[object Object],[object Object]
ERYTHROPOIESIS ,[object Object],[object Object]
ERYTHROPOIETIN ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Physiologic regulation of red cell production
Anemia classification
HYPOPROLIFERATIVE ANEMIAS
HYPOPROLIFERATIVE ANEMIAS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ANEMIA OF CHRONIC DISEASE  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Cytokines effect
ANEMIA OF CHRONIC DISEASE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
TREATMENT ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ANEMIA OF RENAL DISEASE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ANEMIA OF RENAL DISEASE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ANEMIA OF ENDOCRINE DISORDERS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ANEMIA OF ENDOCRINE DISORDERS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ANEMIA OF ENDOCRINE DISORDERS ,[object Object],[object Object],[object Object],[object Object],[object Object]
ANEMIA OF ENDOCRINE DISORDERS ,[object Object],[object Object]
Hypoproliferative Anemias: Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
APLASTIC ANEMIA
DEFINITION ,[object Object],[object Object],[object Object],[object Object],[object Object]
DEFINITION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
EPIDEMIOLOGY  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ETIOLOGY  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ETIOLOGY  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ETIOLOGY  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ETIOLOGY  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ETIOLOGY  ,[object Object],[object Object],[object Object],[object Object]
ETIOLOGY  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ETIOLOGY ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
PATHOPHYSIOLOGY  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
CLINICAL FEATURES  ,[object Object],[object Object],[object Object],[object Object],[object Object]
CLINICAL FEATURES  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
CLINICAL FEATURES ,[object Object],[object Object]
CLINICAL FEATURES ,[object Object],[object Object],[object Object]
LABORATORY STUDIES  ,[object Object],[object Object],[object Object],[object Object],[object Object]
LABORATORY STUDIES  ,[object Object],[object Object],[object Object],[object Object],[object Object]
LABORATORY STUDIES  ,[object Object],[object Object],[object Object],[object Object]
LABORATORY STUDIES  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
DIAGNOSIS  ,[object Object],[object Object],[object Object]
PROGNOSIS  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
TREATMENT  ,[object Object],[object Object]
TREATMENT  ,[object Object],[object Object],[object Object]
TREATMENT  ,[object Object],[object Object],[object Object]
TREATMENT  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
TREATMENT  ,[object Object],[object Object],[object Object],[object Object],[object Object]
TREATMENT  ,[object Object],[object Object],[object Object],[object Object],[object Object]

More Related Content

What's hot

Anemia, types and causes
Anemia, types and causesAnemia, types and causes
Anemia, types and causesAamir Farooq
 
Interpretation of histograms
Interpretation of histogramsInterpretation of histograms
Interpretation of histogramsPankaj Gupta
 
Haematopoiesis & Approach to anaemia
Haematopoiesis & Approach to anaemiaHaematopoiesis & Approach to anaemia
Haematopoiesis & Approach to anaemiaYudh Dev Singh
 
leukemoid reaction and leukemia
leukemoid reaction and leukemialeukemoid reaction and leukemia
leukemoid reaction and leukemiapriya jaswani
 
Classification Of Anaemia & Ida
Classification Of Anaemia & IdaClassification Of Anaemia & Ida
Classification Of Anaemia & IdaSusheela Innah
 
normal and abnormalities in red blood cell
normal and abnormalities in red blood cellnormal and abnormalities in red blood cell
normal and abnormalities in red blood cellRfa Mohd
 
Rational use of blood component
Rational use of blood componentRational use of blood component
Rational use of blood componentKaipol Takpradit
 
Interpretation of cbc 2
Interpretation of cbc 2Interpretation of cbc 2
Interpretation of cbc 2Rakesh Verma
 
Myeloproliferative
MyeloproliferativeMyeloproliferative
Myeloproliferativeraj kumar
 
Hemolytic anemia, Hereditary spherocytosis and G6PD deficiency
Hemolytic anemia, Hereditary spherocytosis and G6PD deficiencyHemolytic anemia, Hereditary spherocytosis and G6PD deficiency
Hemolytic anemia, Hereditary spherocytosis and G6PD deficiencyThe Medical Post
 
Laboratory Diagonosis thalassemia Chirantan
Laboratory Diagonosis  thalassemia Chirantan Laboratory Diagonosis  thalassemia Chirantan
Laboratory Diagonosis thalassemia Chirantan Chirantan MD
 
Interpretation of cbc
Interpretation of cbcInterpretation of cbc
Interpretation of cbcAlaa Abozied
 
Thalassemias - Diagnosis and Management
Thalassemias - Diagnosis and ManagementThalassemias - Diagnosis and Management
Thalassemias - Diagnosis and ManagementDr. Anup Gopinath
 
Hemoglobin and hematocrit determination
Hemoglobin and hematocrit determinationHemoglobin and hematocrit determination
Hemoglobin and hematocrit determinationJay Edneil Olivar
 
RBC Histogram
RBC HistogramRBC Histogram
RBC Histogramjadcaesar
 

What's hot (20)

Anemia, types and causes
Anemia, types and causesAnemia, types and causes
Anemia, types and causes
 
Interpretation of histograms
Interpretation of histogramsInterpretation of histograms
Interpretation of histograms
 
Haematopoiesis & Approach to anaemia
Haematopoiesis & Approach to anaemiaHaematopoiesis & Approach to anaemia
Haematopoiesis & Approach to anaemia
 
leukemoid reaction and leukemia
leukemoid reaction and leukemialeukemoid reaction and leukemia
leukemoid reaction and leukemia
 
Macrocytic anemia
Macrocytic anemiaMacrocytic anemia
Macrocytic anemia
 
Classification Of Anaemia & Ida
Classification Of Anaemia & IdaClassification Of Anaemia & Ida
Classification Of Anaemia & Ida
 
normal and abnormalities in red blood cell
normal and abnormalities in red blood cellnormal and abnormalities in red blood cell
normal and abnormalities in red blood cell
 
sideroblastic anemia
sideroblastic anemiasideroblastic anemia
sideroblastic anemia
 
cbc Histogram
cbc Histogramcbc Histogram
cbc Histogram
 
Megaloblastic anemia
Megaloblastic anemiaMegaloblastic anemia
Megaloblastic anemia
 
Polycythemia
PolycythemiaPolycythemia
Polycythemia
 
Rational use of blood component
Rational use of blood componentRational use of blood component
Rational use of blood component
 
Interpretation of cbc 2
Interpretation of cbc 2Interpretation of cbc 2
Interpretation of cbc 2
 
Myeloproliferative
MyeloproliferativeMyeloproliferative
Myeloproliferative
 
Hemolytic anemia, Hereditary spherocytosis and G6PD deficiency
Hemolytic anemia, Hereditary spherocytosis and G6PD deficiencyHemolytic anemia, Hereditary spherocytosis and G6PD deficiency
Hemolytic anemia, Hereditary spherocytosis and G6PD deficiency
 
Laboratory Diagonosis thalassemia Chirantan
Laboratory Diagonosis  thalassemia Chirantan Laboratory Diagonosis  thalassemia Chirantan
Laboratory Diagonosis thalassemia Chirantan
 
Interpretation of cbc
Interpretation of cbcInterpretation of cbc
Interpretation of cbc
 
Thalassemias - Diagnosis and Management
Thalassemias - Diagnosis and ManagementThalassemias - Diagnosis and Management
Thalassemias - Diagnosis and Management
 
Hemoglobin and hematocrit determination
Hemoglobin and hematocrit determinationHemoglobin and hematocrit determination
Hemoglobin and hematocrit determination
 
RBC Histogram
RBC HistogramRBC Histogram
RBC Histogram
 

Viewers also liked

Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...MD Specialclass
 
10.29.089(b): Blood and Bone Marrow
10.29.089(b): Blood and Bone Marrow10.29.089(b): Blood and Bone Marrow
10.29.089(b): Blood and Bone MarrowOpen.Michigan
 
The DOTS 103 - Before You Start Your Day
The DOTS 103 - Before You Start Your DayThe DOTS 103 - Before You Start Your Day
The DOTS 103 - Before You Start Your DayTimothy Lie
 
Cancer and metastasis
Cancer and metastasisCancer and metastasis
Cancer and metastasisSandeep Kumar
 
Peripheral blood smear
Peripheral blood smearPeripheral blood smear
Peripheral blood smearHummd Mdhum
 
Thrombotic Thrombocytopenic Purpura
Thrombotic Thrombocytopenic PurpuraThrombotic Thrombocytopenic Purpura
Thrombotic Thrombocytopenic PurpuraShakeel Arif
 
Bone marrow biopsy and interpretation
Bone marrow biopsy and interpretationBone marrow biopsy and interpretation
Bone marrow biopsy and interpretationsofisudha
 
Fanconi anemia
Fanconi anemiaFanconi anemia
Fanconi anemia9849514944
 
Guideline report format
Guideline report formatGuideline report format
Guideline report formatAlia Najiha
 
Biology And Pathophysiology Of Cancer
Biology And Pathophysiology Of CancerBiology And Pathophysiology Of Cancer
Biology And Pathophysiology Of CancerRHMBONCO
 
Bone marrow aspiration
Bone marrow aspirationBone marrow aspiration
Bone marrow aspirationDeepa Shrestha
 

Viewers also liked (20)

Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...
 
Bone marrow morphology
Bone marrow morphologyBone marrow morphology
Bone marrow morphology
 
10.29.089(b): Blood and Bone Marrow
10.29.089(b): Blood and Bone Marrow10.29.089(b): Blood and Bone Marrow
10.29.089(b): Blood and Bone Marrow
 
patho midterm 2010
 patho midterm 2010 patho midterm 2010
patho midterm 2010
 
The DOTS 103 - Before You Start Your Day
The DOTS 103 - Before You Start Your DayThe DOTS 103 - Before You Start Your Day
The DOTS 103 - Before You Start Your Day
 
Cirrhosis
CirrhosisCirrhosis
Cirrhosis
 
My.tuberculosis
My.tuberculosisMy.tuberculosis
My.tuberculosis
 
Neoplasia review
Neoplasia reviewNeoplasia review
Neoplasia review
 
Chemoprophylaxis
ChemoprophylaxisChemoprophylaxis
Chemoprophylaxis
 
Electron transport chain
Electron transport chainElectron transport chain
Electron transport chain
 
Cancer and metastasis
Cancer and metastasisCancer and metastasis
Cancer and metastasis
 
Peripheral blood smear
Peripheral blood smearPeripheral blood smear
Peripheral blood smear
 
Thrombotic Thrombocytopenic Purpura
Thrombotic Thrombocytopenic PurpuraThrombotic Thrombocytopenic Purpura
Thrombotic Thrombocytopenic Purpura
 
Bone marrow biopsy and interpretation
Bone marrow biopsy and interpretationBone marrow biopsy and interpretation
Bone marrow biopsy and interpretation
 
Fanconi anemia
Fanconi anemiaFanconi anemia
Fanconi anemia
 
Hypopituitarism
HypopituitarismHypopituitarism
Hypopituitarism
 
Guideline report format
Guideline report formatGuideline report format
Guideline report format
 
Biology And Pathophysiology Of Cancer
Biology And Pathophysiology Of CancerBiology And Pathophysiology Of Cancer
Biology And Pathophysiology Of Cancer
 
Bone marrow aspiration
Bone marrow aspirationBone marrow aspiration
Bone marrow aspiration
 
Dots, lines and planes
Dots, lines and planesDots, lines and planes
Dots, lines and planes
 

Similar to Introduction to Hematology and Anemia Classification

Bone marrow blood comp. (8)
Bone marrow blood comp. (8)Bone marrow blood comp. (8)
Bone marrow blood comp. (8)mujjtombel67
 
Approach to a patient of anemia1 copy
Approach to a patient of anemia1   copyApproach to a patient of anemia1   copy
Approach to a patient of anemia1 copySachin Verma
 
Lecture 5 - 6th week.pptx
Lecture 5 - 6th week.pptxLecture 5 - 6th week.pptx
Lecture 5 - 6th week.pptxAshrafAlikhan17
 
Anaemia, Erythropoiesis
Anaemia, ErythropoiesisAnaemia, Erythropoiesis
Anaemia, ErythropoiesisAlok Kumar
 
2 Hematopoiesis.pptgisgwvjshhsvffghvvgsz
2 Hematopoiesis.pptgisgwvjshhsvffghvvgsz2 Hematopoiesis.pptgisgwvjshhsvffghvvgsz
2 Hematopoiesis.pptgisgwvjshhsvffghvvgszsiddarthsaini007
 
complete blood count.ppt
complete blood count.pptcomplete blood count.ppt
complete blood count.pptSakar Ahmed
 
Approach to a case of anemia
Approach to a case of anemiaApproach to a case of anemia
Approach to a case of anemiaRahul Arya
 
Erythocyte
ErythocyteErythocyte
Erythocytejinx11
 
ERYTHROPOIESIS.pptx
ERYTHROPOIESIS.pptx ERYTHROPOIESIS.pptx
ERYTHROPOIESIS.pptx FatimaSundus1
 
Red Blood Cell
Red Blood CellRed Blood Cell
Red Blood CellAyuB Ali
 
2.blood 2014.pptx
2.blood 2014.pptx2.blood 2014.pptx
2.blood 2014.pptxhamda61
 
The complete blood count (cbc)
The complete blood count (cbc)The complete blood count (cbc)
The complete blood count (cbc)Muhammad Ahmad
 
Introduction to Hematology and Anemia
Introduction to Hematology and AnemiaIntroduction to Hematology and Anemia
Introduction to Hematology and AnemiaThe Medical Post
 
Interpreting the c.b.c differential blood film Examination(part 1)
Interpreting the c.b.c  differential blood film Examination(part 1)Interpreting the c.b.c  differential blood film Examination(part 1)
Interpreting the c.b.c differential blood film Examination(part 1)Ahmed Redwan
 

Similar to Introduction to Hematology and Anemia Classification (20)

Bone marrow blood comp. (8)
Bone marrow blood comp. (8)Bone marrow blood comp. (8)
Bone marrow blood comp. (8)
 
Approach to a patient of anemia1 copy
Approach to a patient of anemia1   copyApproach to a patient of anemia1   copy
Approach to a patient of anemia1 copy
 
erythropioesis
erythropioesiserythropioesis
erythropioesis
 
Lecture 5 - 6th week.pptx
Lecture 5 - 6th week.pptxLecture 5 - 6th week.pptx
Lecture 5 - 6th week.pptx
 
Anaemia, Erythropoiesis
Anaemia, ErythropoiesisAnaemia, Erythropoiesis
Anaemia, Erythropoiesis
 
Blood
BloodBlood
Blood
 
Erythropoiesis for bs mlt
Erythropoiesis  for bs mltErythropoiesis  for bs mlt
Erythropoiesis for bs mlt
 
ANAEMIAS by Dr DELE
ANAEMIAS by Dr DELEANAEMIAS by Dr DELE
ANAEMIAS by Dr DELE
 
2 Hematopoiesis.pptgisgwvjshhsvffghvvgsz
2 Hematopoiesis.pptgisgwvjshhsvffghvvgsz2 Hematopoiesis.pptgisgwvjshhsvffghvvgsz
2 Hematopoiesis.pptgisgwvjshhsvffghvvgsz
 
complete blood count.ppt
complete blood count.pptcomplete blood count.ppt
complete blood count.ppt
 
Approach to a case of anemia
Approach to a case of anemiaApproach to a case of anemia
Approach to a case of anemia
 
Erythocyte
ErythocyteErythocyte
Erythocyte
 
ERYTHROPOIESIS.pptx
ERYTHROPOIESIS.pptx ERYTHROPOIESIS.pptx
ERYTHROPOIESIS.pptx
 
Red Blood Cell
Red Blood CellRed Blood Cell
Red Blood Cell
 
2.blood 2014.pptx
2.blood 2014.pptx2.blood 2014.pptx
2.blood 2014.pptx
 
The complete blood count (cbc)
The complete blood count (cbc)The complete blood count (cbc)
The complete blood count (cbc)
 
Anemia class019.pptx
Anemia class019.pptxAnemia class019.pptx
Anemia class019.pptx
 
BLOOD.pdf
BLOOD.pdfBLOOD.pdf
BLOOD.pdf
 
Introduction to Hematology and Anemia
Introduction to Hematology and AnemiaIntroduction to Hematology and Anemia
Introduction to Hematology and Anemia
 
Interpreting the c.b.c differential blood film Examination(part 1)
Interpreting the c.b.c  differential blood film Examination(part 1)Interpreting the c.b.c  differential blood film Examination(part 1)
Interpreting the c.b.c differential blood film Examination(part 1)
 

More from MD Specialclass

More from MD Specialclass (20)

Git diseases presentn no. 2 applied nutrition
Git diseases presentn no. 2 applied nutritionGit diseases presentn no. 2 applied nutrition
Git diseases presentn no. 2 applied nutrition
 
Getting ahead of headaches
Getting ahead of headachesGetting ahead of headaches
Getting ahead of headaches
 
Acute brain attack 911
Acute brain attack  911Acute brain attack  911
Acute brain attack 911
 
EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL
 
EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL
 
Fever & id diet final
Fever & id diet finalFever & id diet final
Fever & id diet final
 
Eating disorders
Eating disordersEating disorders
Eating disorders
 
Hepatocellular carcinoma
Hepatocellular carcinomaHepatocellular carcinoma
Hepatocellular carcinoma
 
Eating disorders
Eating disordersEating disorders
Eating disorders
 
Normal sleep and sleep disorders
Normal sleep and sleep disordersNormal sleep and sleep disorders
Normal sleep and sleep disorders
 
Tic disorder
Tic disorderTic disorder
Tic disorder
 
Thyroid
ThyroidThyroid
Thyroid
 
Dermatology dr.n.ramos
Dermatology   dr.n.ramosDermatology   dr.n.ramos
Dermatology dr.n.ramos
 
Tic disorder
Tic disorderTic disorder
Tic disorder
 
Toxic and drug induced hepatitis
Toxic and drug induced hepatitisToxic and drug induced hepatitis
Toxic and drug induced hepatitis
 
Pancreatic disease
Pancreatic diseasePancreatic disease
Pancreatic disease
 
Liver disease
Liver diseaseLiver disease
Liver disease
 
Complications of cirrhosis
Complications of cirrhosisComplications of cirrhosis
Complications of cirrhosis
 
Chronic hep b
Chronic hep bChronic hep b
Chronic hep b
 
Amoebic liver abscess
Amoebic liver abscessAmoebic liver abscess
Amoebic liver abscess
 

Introduction to Hematology and Anemia Classification

Editor's Notes

  1. There are three types of granulocyte named according to their staining characteristics in blood films. They are neutrophils, eosinophils and basophils. Mononuclear cells are divided into lymphocytes and monocytes.
  2. Eosinophils have granules which take up the acidic dye, eosin, hence their name. Eosinophil granules stain orange and usually pack the cytoplasm The eosinophil is produced in the bone marrow. It is released into the blood stream where it spends, on average, about 6 hours before migrating to tissues. Eosinophil functions include chemotaxis, phagocytosis and killing of bacteria and parasites. Eosinophils have harmful as well as beneficial effects, being implicated in allergic disease.
  3. Basophils are produced in the bone marrow. They are released into the blood and then migrate into tissues. They have a role in allergic and inflammatory responses.
  4. B lymphocytes differentiate into antibody-secreting plasma cells. The role of T lymphocytes and natural killer cells is in cell-mediated immunity.
  5. Large lymphocytes sometimes have a visible nucleolus, a small round or oval structure within the nucleus which stains more lightly than the rest of the nucleus. The nucleolus is the site of synthesis and processing of ribosomal nucleic acid (RNA). Large lymphocytes may be either B, T or NK cells. They are somewhat more frequent in children than in adults.
  6. Large granular lymphocytes include cytotoxic T lymphocytes and natural killer cells. Cytotoxic T cells are responsible for HLA-dependent cell-mediated immunity. Natural killer cells are responsible for HLA-independent cell mediated immunity
  7. Monocytes are produced in the bone marrow. They spend several days in the circulation before migrating to the tissues where they differentiate into macrophages. Macrophages are also known as histiocytes. Monocytes and macrophages are phagocytic and can kill ingested bacteria and fungi. distinguished from large granular lymphocytes by their larger size, more opaque greyish cytoplasm and finer although often more numerous granules cytoplasmic outline is irregular and may be indented by surrounding red cells
  8. neutrophils in the circulating blood are mainly mature segmented neutrophils smaller numbers of cells of neutrophil lineage with non-segmented nuclei. They are referred to as. They are less mature than segmented neutrophils. An increased number of band cells is referred to as a 'left shift'.
  9. Platelets are produced in the bone marrow by demarcation of small areas of megakaryocyte cytoplasm which are then released into bone marrow sinusoids and thus into the circulating blood. Some budding of platelets may also occur from megakaryocytes lodged in pulmonary capillaries. Pulmonary megakaryocytes are derived from the bone marrow. composed of a central granulomere containing azurophilic granules and a peripheral hyalomere that is agranular
  10. measurements of iron supply including serum iron, total iron-binding capacity (TIBC; an indirect measure of the transferrin level), and serum ferritin description of both the red and white cells, a white cell differential count, and the platelet count. may be important to assist in the diagnosis.
  11. complete blood count (CBC) physiologic factors affect the normal CBC values including age, gender, pregnancy, smoking, and altitude High-normal hemoglobin values may be seen in men and women who live at altitude or smoke heavily. Hemoglobin elevations due to smoking reflect normal compensation due to the displacement of O2 by CO in hemoglobin binding. reticulocyte count
  12. a complement to the red cell indices The degree of anisocytosis usually correlates with increases in the RDW or the range of cell sizes. Poikilocytosis suggests a defect in the maturation of red cell precursors in the bone marrow or fragmentation of circulating red cells The blood smear may also reveal polychromasia — red cells that are slightly larger than normal and grayish blue in color on the Wright-Giemsa stain. These cells are reticulocytes that have been prematurely released from the bone marrow, and their color represents residual amounts of ribosomal RNA. These cells appear in circulation in response to EPO1 stimulation or to architectural damage of the bone marrow (fibrosis, infiltration of the marrow by malignant cells, etc.) that results in their disordered release from the marrow. The appearance of nucleated red cells, Howell-Jolly bodies, target cells, sickle cells, and others may provide clues to specific disorders
  13. Anisocytosis is a common, non-specific abnormality which can be associated with almost any type of anaemia. It is therefore not particularly useful in making a specific diagnosis. Anisochromasia indicates a changing situation, i.e. that haemoglobin synthesis has been reduced during production of some of the circulating red cells. It is usually caused by iron deficiency or 'anaemia of chronic disease'. When there is anisocytosis automated full blood counters show an increase in the RDW (red cell distribution width), a measurement of the amount of variation in red cell size. Some instruments can also measure the variation in the degree of haemoglobinization of individual red cells. In the presence of anisochromasia such instruments show an increase in the HDW (haemoglobin distribution width). Some cells are normally haemoglobinized while others show only a thin rim of haemoglobinized cytoplasm
  14. suggests a defect in the maturation of red cell precursors in the bone marrow or fragmentation of circulating red cells
  15. The reticulocyte count is often expressed as a percentage of red cells but is better expressed as an absolute count. The normal range is approximately 0.5-2% or 40-140 X 109/l. identified on a reticulocyte preparation rather than on a blood film stained in the normal way
  16. With anemia, the percentage of reticulocytes may be increased while the absolute number is unchanged Abs retic = retic % x rbc count Nv after correction is same as normal retic va;es 0.5-1.5%
  17. Correction of the reticulocyte count. In order to use the reticulocyte count as an indicator of effective red cell production, the reticulocyte number must be corrected based on the level of anemia and the circulating life span of the reticulocytes. Erythroid cells take ~4.5 days to mature. At normal hematocrit levels, they are released to the circulation with ~1 day left as reticulocytes. However, with different levels of anemia, erythroid cells are released from the marrow prematurely. Most patients come to clinical attention with hematocrits in the mid-20s and thus a correction factor of 2 is commonly used because the observed reticulocytes will live for 2 days in the circulation before losing their RNA. NORMAL bm activity RPI IS 1 Hemolysis 3 to 7 x higher Bone marrow damage index is 2 or less Measures erythropooietic act when stress retic are present, rationale of obtaining this value is that life span of circulating stress retic in 2 days instead of 1 TO compensate for the increased maturation time and consequent retention of residuals
  18. +polychromatophilic macrocytes correction is necessary because these prematurely released cells survive as reticulocytes in circulation for >1 day, providing a falsely high estimate of daily red cell production divided by 2 to account for the prolonged reticulocyte maturation time -polychromatophilic cells second correction is not required doubly corrected reticulocyte count is the reticulocyte production If the reticulocyte production index is <2 in the face of established anemia, a defect in erythroid marrow proliferation or maturation must be present.
  19. Iron studies reflect the availability of iron for hemoglobin synthesis Percent transferrin saturation derived by dividing the serum iron level (× 100) by the TIBC transferrin saturation ranges from 25 to 50% diurnal variation in the serum iron leads to a variation in the percent transferrin saturation Serum ferritin to evaluate total-body iron stores Adult males have serum ferritin levels that average about 100 ug/L, corresponding to iron stores of about 1 g Adult females have lower serum ferritin levels averaging 30 ug/L, reflecting lower iron stores serum ferritin level of 10 to 15 ug/L represents depletion of body iron stores ferritin is also an acute-phase reactant and, in the presence of acute or chronic inflammation, may rise severalfold above baseline levels As a rule, a serum ferritin >200 ug/L means there is at least some iron in tissue stores.
  20. Bone marrow aspiration and biopsy. After a small area of skin is numbed, a Jamshidi needle (a long, hollow needle) is inserted into the patient’s hip bone. Samples of blood, bone, and bone marrow are removed for examination under a microscope.
  21. The storage iron is in the form of ferritin or hemosiderin. On carefully prepared bone marrow smears, small ferritin granules can normally be seen in 20 to 40% of developing erythroblasts. Such cells are called sideroblasts
  22. Even films without fragments are worth examining as useful information may be gained. However, assessment of cellularity and megakaryocyte numbers is unreliable and dilution with peripheral blood may lead to lymphocytes and neutrophils being over-represented in the differential count. make sure that particles or fragments are present Bone marrow aspirates which lack particles may be diluted with peripheral blood and may therefore be unrepresentative
  23. Continuing with a low power examination, the number of megakaryocytes should be assessed. Most megakaryocytes [arrows] are large cells which can be identified with low power. Their numbers are very variable in normal bone marrow films, being partly related to the number of fragments present. This image shows increased megakaryocyte numbers.
  24. A mature megakaryocyte sheds almost all its cytoplasm as platelets which are released into the circulating blood.
  25. When there is iron deficiency the bone marrow iron stain shows no blue staining. Initial assessment should be with a medium power objective but absent iron should be confirmed by examination with a X 100 oil objective. If an adequate number of fragments are present, e.g. five to six fragments, this should be reported as 'absent storage iron'. Once all normal and abnormal bone marrow cells have been assessed on a routine stain an iron stain should be examined, using a medium power objective (X 40 or X 50). Storage iron, which stains blue, should be assessed in bone marrow fragments. This image shows normal bone marrow iron.
  26. Commitment of the stem cell to the specific cell lineages appears not to be regulated by known exogenous growth factors or cytokines Following lineage commitment (or differentiation), hematopoietic progenitor and precursor cells come increasingly under the regulatory influence of growth factors and hormones
  27. Pronormoblast 20-25um Baso 16 to 18um Poly 12 to 15 Ortho 10 to 15
  28. stimulus for EPO production is the availability of O2 for tissue metabolic needs produced and released by peritubular capillary lining cells within the kidney (highly specialized epithelial-like cells) Impaired O2 delivery to the kidney can result from a decreased red cell mass (anemia) impaired O2 loading of the hemoglobin molecule (hypoxemia) impaired blood flow to the kidney (renal artery stenosis) normal level 10 to 25 U/L hemoglobin concentration falls below 100 to 120 g/L (10 to 12 g/dL), plasma EPO levels increase in proportion to the severity of the anemia
  29. Hypoproliferative anemias are the most common anemias and anemia associated with acute and chronic inflammation is the most common of these. The anemia of acute and chronic inflammation, like iron deficiency, is related in part to abnormal iron metabolism. The anemias associated with renal disease, inflammation, cancer, and hypometabolic states are characterized by an abnormal erythropoietin response to anemia.
  30. most important in the differential diagnosis of iron deficiency, many of the features brought about by inadequate iron delivery to the marrow, despite the presence of normal or increased iron stores serum ferritin values are often the most distinguishing feature between true iron deficiency anemia and the iron-deficient erythropoiesis associated with inflammation. Typically, serum ferritin values increase threefold over basal levels in the face of inflammation. All of these changes are due to the effects of inflammatory cytokines and hepcidin, the storage iron regulator, acting at several levels of erythropoiesis
  31. level of the anemia correlates with the severity of the renal failure PTH Suppress erythropoiesis by renal calcification (decreased EPO formation) marrow sclerosis ( decreased proliferation of erythroid precursors)
  32. ; tissues dependent on active mitosis are particularly susceptible Nuclear accidents can involve not only power plant workers but also employees of hospitals, laboratories, and industry (food sterilization, metal radiography, etc.), as well as innocents exposed to stolen, misplaced, or misused sources. While the radiation dose can be approximated from the rate and degree of decline in blood counts, dosimetry by reconstruction of the exposure can help to estimate the patient's prognosis and also to protect medical personnel from contact with radioactive tissue and excreta.
  33. association between marrow failure and other chemicals is much less well substantiated
  34. Aplasia is a major consequence and the cause of death in transfusion-associated graft-versus-host disease, which can occur after infusion of unirradiated blood products to an immunodeficient recipient plastic anemia is strongly associated with the rare collagen vascular syndrome called eosinophilic fasciitis, which is characterized by painful induration of subcutaneous tissues (Chap. 303). Pancytopenia with marrow hypoplasia can also occur in systemic lupus erythematosus
  35. Patients with an initial clinical diagnosis of PNH, especially younger individuals, may later develop frank marrow aplasia and pancytopenia patients with an initial diagnosis of aplastic anemia may suffer from hemolytic PNH years after recovery of blood counts
  36. . The common X-linked variety is due to mutations in the DKC1 (dyskerin) gene; the more unusual autosomal dominant type has been linked to hTERC, the RNA component of the telomerase complex. These two gene products cooperate in maintaining telomere length.
  37. cells bearing the CD34 antigen, a marker of early hematopoietic cells, are greatly diminished
  38. days to weeks of easy bruising, oozing from the gums, nose bleeds, heavy menstrual flow, and sometimes petechiae will have been noticed. With thrombocytopenia, massive hemorrhage is unusual, but small amounts of bleeding in the central nervous system can result in catastrophic intracranial or retinal hemorrhage. , including lassitude, weakness, shortness of breath, and a pounding sensation in the ears. Infection is an unusual first symptom in aplastic anemia (unlike in agranulocytosis, where pharyngitis, anorectal infection, or frank sepsis occur early).
  39. . Patient with Fanconi's anaemia showing short stature, hypoplastic thumbs and a typical 'Fanconi's facies' - small eyes, small chin and small mouth A central venous line has been inserted in preparation for bone marrow transplantation. autosomally recessive inherited conditions characterized by susceptibility to chromosome breakage and progressive bone marrow failure
  40. severe aplasia, may show only red cells, residual lymphocytes, and stromal cells Residual hematopoietic cells should have normal morphology, except for mildly megaloblastic erythropoiesis; megakaryocytes are invariably greatly reduced and usually absent
  41. showing a large poorly formed erythroblastic island with increased numbers of early erythroblasts
  42. Human leukocyte antigen (HLA) typing should be ordered as soon as the diagnosis of aplastic anemia is established in a child or younger adult. In transplant candidates, transfusion of blood from family members should be avoided so as to prevent sensitization to histocompatibility antigens; while transfusions in general should be minimized, limited numbers of blood products probably do not seriously affect outcome.